Live Breaking News & Updates on Project bioshield

Stay informed with the latest breaking news from Project bioshield on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Project bioshield and stay connected to the pulse of your community

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

United-states , United-kingdom , American , Brian-poligone , Journal-of-the-european-academy-dermatology , Our-public-health-solutions , Development-authority , Nasdaq , Journal-of-the-american-medical-association , Soligenix-inc , Exchange-commission , National-institute-of-allergy

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

South-africa , United-states , United-kingdom , Sudan , Christopherj-schaber , Us-congress , Our-public-health-solutions , Development-authority , Prnewswire-soligenix-inc , Twitter , Exchange-commission

Soligenix to Present at Upcoming Conferences

PRINCETON, N.J., May 6, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

Linkedin , Development-authority , Exchange-commission , Soligenix-inc , Twitter , Nasdaq , Our-public-health-solutions , Us-congress , Biomedical-advanced-research , Defense-threat-reduction-agency , National-institute-of-allergy

The Bush Administration's Secret Biowarfare Agenda

By Stephen Ledman / medialeft.com / July 30, 2008 When it comes to observing US and international laws, treaties and norms, the Bush administration is a serial offender. Since 2001, it's: -- spurned efforts for nuclear disarmament to advance its weapons program and retain current stockpiles; -- renounced the 1970 Nuclear Non-Proliferation Treaty (NPT) and…

Italy , Cuba , United-states , California , London , City-of , United-kingdom , Fort-detrick , Maryland , Jakarta , Jakarta-raya , Indonesia

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tanzania , United-kingdom , Sudan , Equatorial-guinea , South-africa , Ghana , Uganda , Hawaii , United-states , White-house , District-of-columbia , American

Form 424B3 Spectral AI, Inc.

Form 424B3 Spectral AI, Inc.
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , United-kingdom , Cayman-islands , Welwyn-garden-city , Hertfordshire , Dublin , Ireland , Time-to , Sicilia , Italy , China , State-of-delaware

Soligenix Announces Pricing of $4.75 Million Public Offering

PRINCETON, N.J., April 18, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

New-york , United-states , National-institute-of-allergy , Us-congress , Nasdaq , Exchange-commission , Defense-threat-reduction-agency , Development-authority , A-gp-alliance-global-partners , Our-public-health-solutions , Prnewswire-soligenix-inc

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

United-states , Uganda , Sudan , Axel-lehrer , Oreola-donini , Our-public-health-solutions , Us-congress , Exchange-commission , Soligenix-inc , Twitter , Drug-administration , Defense-threat-reduction-agency

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

United-states , Biomedical-advanced-research , Linkedin , Exchange-commission , Us-congress , Nasdaq , Prnewswire-soligenix-inc , European-medicines-agency , Twitter , Defense-threat-reduction-agency , Development-authority

Spectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Spectral AI Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions].

Texas , United-states , United-kingdom , American , John-vandermosten , Vince-capone , Ryan-zimmerman , Pete-carlson , Peter-carlson , Carl-byrnes , Vincent-capone , Devin-sullivan